Francesco Micheli Net Worth & Insider Trades

Francesco Micheli Intercept Pharmaceuticals, Inc

As of August 17, 2020

What is Francesco Micheli's Net Worth?

The current estimated net worth of Intercept Pharmaceuticals, Inc's Francesco Micheli is estimated to be about $470.07M . Francesco Micheli owns about 4,000,000 units of Intercept Pharmaceuticals, Inc common stock. In the last 7 years at Intercept Pharmaceuticals, Inc, Francesco Micheli has sold an estimated value of $389.44M worth.

What is Francesco Micheli's Past Insider Trading?

Francesco Micheli's largest purchase order was 390,625 units , worth over $25M on April 9, 2018. Francesco Micheli's largest sale order was 349,318 units , worth over $110.98M on April 11, 2014. In total, Francesco Micheli has made about 7 transactions over 7 years of their time at Intercept Pharmaceuticals, Inc. Francesco Micheli usually trades in October and April, with the busiest year in 2020, 2013 and 2018. The most recent transaction was a sale order of 1,500,000 units , worth over $71.25M on August 17, 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Francesco Micheli's' Mailing Address?

  • Mailing address is C/o Genextra S.P.A. Via G. de Grassi, 11 Milan L6 20124 Italy

Intercept Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark Pruzanski, M.D., 2020 $757,850 - $4,113,504 $1,015,996 $531,995 $7,660 $6,427,005
Mark Pruzanski, M.D., 2019 $734,292 - $4,197,742 $1,116,118 $560,265 $7,368 $6,615,785
Mark Pruzanski, M.D., 2018 $702,000 - $1,667,718 $1,705,358 $442,260 $8,623 $4,525,960
Jerome Durso, 2020 $599,524 - $2,057,016 $998,776 $231,737 $21,910 $3,908,963
Jerome Durso, 2019 $573,250 - $2,089,570 $1,238,321 $359,284 $21,368 $4,281,793
Jerome Durso, 2018 $540,800 - $1,554,326 $775,844 $292,032 $22,403 $3,185,406
Sandip Kapadia, 2020 $476,863 - $1,087,836 $528,088 $184,039 $21,910 $2,298,736
Sandip Kapadia, 2019 $464,100 - $1,001,664 $586,573 $252,935 $21,368 $2,326,640
Sandip Kapadia, 2018 $442,000 - $790,164 $393,544 $228,735 $22,403 $1,876,846
Richard Kim, 2020 $456,095 - $1,044,360 $505,128 $168,056 $79,211 $2,252,850
Richard Kim, 2019 $442,900 $202,800 $890,368 $521,398 $265,519 $76,343 $2,399,328
Lisa Bright, 2020 $480,552 - $925,704 $453,467 $240,955 $139,106 $2,239,784
Ryan Sullivan, 2020 $437,107 - $1,087,836 $528,088 - $89,942 $2,142,973
Ryan Sullivan, 2019 $445,520 - $1,471,902 $871,713 $267,089 $21,368 $3,077,592
Ryan Sullivan, 2018 $376,158 - $1,239,112 $1,190,351 $229,122 $173,437 $3,208,180
Christian Weyer, M.D., M.A.S., 2020 $486,731 - $925,704 $453,467 $170,804 $21,910 $2,058,616
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1270073/000110465921055639/tm218121-2_def14a.htm

What are Intercept Pharmaceuticals, Inc's Past Insider Trades?

Intercept Pharmaceuticals, Inc's most recent insider trade came on March 12, 2021 by Srinivas Akkaraju who bought 237,000 units worth $5.02M . In the last 9 years, insiders at Intercept Pharmaceuticals, Inc have sold an estimated value of $1.66B and bought an estimated value of $148.73M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are David Shapiro, Chief Medical Officer,  Mark Pruzanski, Director,  and Lisa Bright, President .

INTERCEPT PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1